The roles of C-reactive protein-albumin ratio as a novel prognostic biomarker in heart failure patients: A systematic review

Roy Bagus Kurniawan, Pratista Oktafia, Pandit Bagus Tri Saputra, Dinda Dwi Purwati, Mahendra Eko Saputra, Irma Maghfirah, Novia Nurul Faizah, Yudi Her Oktaviono, Firas Farisi Alkaff

Research output: Contribution to journalReview articlepeer-review

6 Citations (Scopus)

Abstract

C-Reactive Protein (CRP)-albumin ratio (CAR) is a novel prognostic biomarker that is predicted to be a more reliable indicator than CRP or albumin alone. Therefore, this systematic review aimed to evaluate the role of CAR in predicting poor outcomes of heart failure (HF) patients. We conducted a literature search across ProQuest, PubMed, ScienceDirect, Web of Science, and Scopus. All related studies assessing CAR and reporting mortality outcomes or other adverse outcomes were assessed. A total of five studies with a total of 1821 patients were included in this review. CAR is significantly associated with all-causes in-hospital mortality and out-hospital mortality in patients with acute and chronic heart failure. CAR is associated with higher hospitalization rates, the number of hospitalizations, severe New York Heart Association (NYHA) classification, and the risk of advanced HF. In conclusion, CAR is significantly associated with poor HF outcomes including all-cause mortality (cardiac and non-cardiac death).

Original languageEnglish
Article number102475
JournalCurrent Problems in Cardiology
Volume49
Issue number5
DOIs
Publication statusPublished - May 2024

Keywords

  • Adverse outcome
  • CRP-albumin ratio
  • Heart failure
  • Mortality
  • Prognostic

Fingerprint

Dive into the research topics of 'The roles of C-reactive protein-albumin ratio as a novel prognostic biomarker in heart failure patients: A systematic review'. Together they form a unique fingerprint.

Cite this